Clinical Trials Directory

Trials / Completed

CompletedNCT03944694

White Cell Ratios as Markers of Delirium and Outcome in Acute Ischemic Stroke.

White Cell Ratios as Markers of Delirium and Outcome in Acute Ischemic Stroke. DELirium in Acute Ischemic Stroke [DELIAS]

Status
Completed
Phase
Study type
Observational
Enrollment
1,001 (actual)
Sponsor
Pomeranian Medical University Szczecin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to investigate the role of Neutrophil-to-Lymphocyte Ratio (NLR) and other derived white cell markers as early markers of delirium and outcome after acute ischemic stroke (AIS).

Detailed description

Delirium is an acute brain disorder, potentially reversible, commonly occurring in patients with acute ischemic stroke. The pathomechanism of delirium is related to neuroinflammatory process and oxidative stress. Search for readily available diagnostic marker that will aid clinicians in early identification of delirium is an on-going process. The aim of this study was to investigate the role of Neutrophil-to-Lymphocyte Ratio (NLR) and other derived white cell markers as early markers of delirium and outcome after acute ischemic stroke (AIS).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDelirium assessment.Full blood count analysis.

Timeline

Start date
2015-06-30
Primary completion
2019-03-31
Completion
2019-03-31
First posted
2019-05-09
Last updated
2019-05-10

Source: ClinicalTrials.gov record NCT03944694. Inclusion in this directory is not an endorsement.